Renaissance Technologies LLC Purchases New Shares in NeuroMetrix, Inc. (NASDAQ:NURO)

Renaissance Technologies LLC acquired a new stake in shares of NeuroMetrix, Inc. (NASDAQ:NURO) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 11,560 shares of the medical device company’s stock, valued at approximately $46,000. Renaissance Technologies LLC owned approximately 0.57% of NeuroMetrix at the end of the most recent quarter.

Analyst Upgrades and Downgrades

Separately, StockNews.com started coverage on shares of NeuroMetrix in a report on Wednesday. They set a “sell” rating on the stock.

NeuroMetrix Stock Up 4.4 %

NURO stock opened at $4.55 on Friday. The business has a 50 day moving average of $4.42 and a 200-day moving average of $4.21. The firm has a market cap of $9.37 million, a PE ratio of -0.99 and a beta of 1.82. NeuroMetrix, Inc. has a 12-month low of $2.66 and a 12-month high of $4.73.

NeuroMetrix Company Profile

NeuroMetrix, Inc, a commercial stage neurotechnology company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, and China. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; Quell, a wearable device for symptomatic relief and management of chronic pain; and ADVANCE system offers services to device and provide disposable electrodes to a customer base of hand surgeons and manufacturers for industrial health use.